Estimating the burden of serogroup C meningococcal disease in England and Wales.

Communicable disease and public health / PHLS

Volumn 5, Issue 3, 2002, Pages 213-219

  Davison, K L ^a   Ramsay, M E ^a   Crowcroft, N S ^a   Lieftucht, A ^a   Kaczmarski, E B ^a   Trotter, C L ^a   Gungabissoon, U ^a   Begg, N T ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COST OF ILLNESS; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; MENINGOCOCCOSIS; MIDDLE AGED; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; UNITED KINGDOM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; ENGLAND; FEMALE; HEALTH CARE COSTS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS, SEROGROUP B; NEISSERIA MENINGITIDIS, SEROGROUP C; WALES;

EID: 0036730067     PISSN: 14621843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)